Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A tumor mutational burden-derived immune computational framework selects sensitive immunotherapy/chemotherapy for lung adenocarcinoma populations with different prognoses. | Front Oncol | 2023 | 37456238 | PubTator, text mining | PubMed |
| GEO data mining identifies potential immune-related genes in hypertrophic scar and verities in a rabbit model. | Heliyon | 2023 | 37455989 | PubTator, text mining | PubMed |
| Understanding the Mechanisms of Action and Effects of Drugs of Abuse. | Molecules | 2023 | 37446631 | PubTator, text mining | PubMed |
| Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review. | Int J Mol Sci | 2023 | 37446307 | PubTator, text mining | PubMed |
| Testing for Human Papillomaviruses in Urine, Blood, and Oral Specimens: an Update for the Laboratory. | J Clin Microbiol | 2023 | 37439692 | PubTator, text mining | PubMed |
| Accumulation of plasmacytoid dendritic cell is associated with a treatment response to DNA-damaging treatment and favorable prognosis in lung adenocarcinoma. | Front Immunol | 2023 | 37435086 | PubTator, text mining | PubMed |
| The role of DNA methylation in human pancreatic neuroendocrine tumours. | Endocr Oncol | 2023 | 37434653 | PubTator, text mining | PubMed |
| Uncovering Footprints of Natural Selection Through Spectral Analysis of Genomic Summary Statistics. | Mol Biol Evol | 2023 | 37433019 | PubTator, text mining | PubMed |
| Smoking-related dysregulation of plasma circulating microRNAs: the Rotterdam study. | Hum Genomics | 2023 | 37430296 | PubTator, text mining | PubMed |
Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking. | Front Mol Biosci | 2023 | 37426421 | PubTator, text mining | PubMed |
| Restoring tumor immunogenicity with dendritic cell reprogramming. | Sci Immunol | 2023 | 37418548 | PubTator, text mining | PubMed |
| Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies. | Indian J Ophthalmol | 2023 | 37417104 | PubTator, text mining | PubMed |
| Molecular diagnosis and subtyping of Blastocystis sp.: Association with clinical, colonoscopic, and histopathological findings. | Trop Parasitol | 2023 | 37415748 | PubTator, text mining | PubMed |
| A systematic CRISPR screen reveals redundant and specific roles for Dscam1 isoform diversity in neuronal wiring. | PLoS Biol | 2023 | 37410725 | PubTator, text mining | PubMed |
| Molecular basis of sex differences in cancer: Perspective from Asia. | iScience | 2023 | 37404373 | PubTator, text mining | PubMed |
| Whole genome sequencing identifies genetic variants associated with neurogenic inflammation in rosacea. | Nat Commun | 2023 | 37402769 | PubTator, text mining | PubMed |
| Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer. | Exp Mol Med | 2023 | 37394589 | PubTator, text mining | PubMed |
| A Mendelian randomization study of genetic liability to post-traumatic stress disorder and risk of ischemic stroke. | Transl Psychiatry | 2023 | 37391434 | PubTator, text mining | PubMed |
| ITGAL as a prognostic biomarker correlated with immune infiltrates in melanoma. | Front Oncol | 2023 | 37388230 | PubTator, text mining | PubMed |
| Editorial: Translational research in thyroid cancer, Volume II. | Front Endocrinol (Lausanne) | 2023 | 37383388 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=15